Aspirin and blood pressure lowering drugs can prevent heart disease at a fraction of the cost of cholesterol lowering drugs (statins) and clopidogrel (an anti-clotting drug), finds a study in this week’s BMJ.
Estimates of cost and effectiveness were obtained for aspirin, antihypertensive drugs, statins and clopidogrel. Cost per coronary event was calculated for treatments individually and in combination for patients at various levels of risk.
The most cost effective preventive treatments were aspirin and antihypertensive drugs, whereas simvastatin and clopidogrel were the least cost effective.
For instance, cost per coronary event prevented in a patient at 10% risk over five years was £3,500 for aspirin, £12,500 for initial antihypertensives, £18,300 for intensive antihypertensives, £60,000 for clopidogrel, and £61,400 for simvastatin.
These results cast doubt on present policy, says the author. A more efficient prevention strategy would be to offer most men over 55 and most women over 65 aspirin than to give statins to a few high-risk patients.
Emma Dickinson | Source: alphagalileo
Further information: press.psprings.co.uk/bmj/november/gp1264.pdf
More articles from
Health and Medicine:
Colonial Urbanization in Africa at Dawn of 20th Century Marked Outbreak of HIV
02.10.2008 | University of Arizona
Brain Signal Persists Even in Dreamless Sleep
02.10.2008 | Washington University in St. Louis
Cells that Avoid Suicide May Become Cancerous
02.10.2008 | Life Sciences
02.10.2008 | Life Sciences
New species thanks to different ways of seeing
02.10.2008 | Life Sciences